Died (n = 61) | Survived (n = 22) | p valuea | |
---|---|---|---|
Telemonitored during study periodb | 0.027 | ||
Yes, n (%) | 37 (60.7 %) | 19 (86.4 %) | |
No, n (%) | 24 (39.3 %) | 3 (13.6 %) | |
Condition prompting inclusion | 0.888 | ||
Lung disease (78.6 % COPD) | 14 (22.9 %) | 6 (27.3 %) | |
Heart failure | 13 (21.3 %) | 5 (22.7 %) | |
Both concurrently | 34 (55.8 %) | 11 (50 %) | |
Sex | 0.889 | ||
Female | 26 (42.6 %) | 9 (40.9 %) | |
Male | 35 (57.4 %) | 13 (59.1 %) | |
Age in years on inclusion, median (IQR) | 81 (78 to 87) | 81.3 (71 to 84) | 0.192 |
Barthel index score (0 to 100) | 70 (40 to 87.5) | 87.5 (60 to 100) | 0.120 |
EQ-5D VAS scorec (0 to 100) | 40 (25 to 60) | 50 (37.5 to 65) | 0.148 |
Number of regular medications | 11 (9 to 13) | 12 (10 to 14) | 0.219 |
Number of all-cause admissions the year before inclusion | 3 (2 to 4) | 3 (1 to 4) | 0.384 |
Number of condition-specific (heart or lung-related) admissions the year before inclusion | 2 (2 to 3) | 2 (1 to 2) | 0.006 |